TAK

Takeda Pharmaceutical Company Limited
D

TAK

14.615
USD
0.19
(1.32%)
مغلق
حجم التداول
108,968
الربح لكل سهم
137
العائد الربحي
4.61
P/E
50
حجم السوق
46,157,382,465
أصول ذات صلة الأخبار المقالات

العنوان: Takeda Pharmaceutical Company Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.